Xeris Pharmaceuticals | XERS - Market Capitalization


Xeris Pharmaceuticals reported $848.3M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pharma Mar EUR 1.35B 283.5M Dec/2025
Qiagen NV USD 9.9B 207.4M Dec/2025
Sartorius EUR 16.41B 2.95B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Zealand Pharma A/S 33.35B 0 Apr/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025